A Danish study of nationwide registries estimated a 39% greater risk of high refractive error among children of mothers with hypertensive disorder of pregnancy (HDP), a complication that affects 5% to 10% of pregnancies.
Children of mothers with hypertensive disorder of pregnancy (HDP) should be screened early and regularly for refractive error (RE), suggest study findings published in JAMA Network Open.
The Danish study of nationwide registries estimated a 39% greater risk of high RE among children of mothers with HDP, a complication that affects 5% to 10% of pregnancies. This includes overall risk, as well as specific risks for hyperopia, myopia, and astigmatism.
The study adds to existing data pointing to HDP being associated with short- and long-term consequences in pregnant women and their children.
“Previous studies reported that maternal HDP may be associated with abnormal visual development and eye disease in offspring. A case-control study with 77 children showed that mothers of children with congenital myopia were more likely to have hypertension during pregnancy,” detailed the researchers. “However, whether or to what extent prenatal exposure to maternal HDP is associated with increased risk of overall high RE and specific types of RE, including myopia, hyperopia, and astigmatism, in offspring in childhood and adolescence remains unknown.”
Data from over 2 million children born over 4 decades showed that 0.90% of the 900 children of mothers with HDP and 0.64% of the 2.4 million children of mothers without HDP received a diagnosis of high RE throughout 18 years of follow-up.
The increased risk of high RE was highest among children of mothers with early-onset and severe preeclampsia (HR, 2.59; 95% CI, 2.17-3.08), and the risk spanned across age groups between birth and 12 years. The researchers observed an HR of 1.51 (95% CI, 1.38-1.65) among patients aged 0 to 6 years and an HR of 1.28 (95% CI, 1.11-1.47) among patients aged 7 to 12 years. While there was an increased risk observed among patients aged 13 to 18 years (HR, 1.16; 95% CI, 0.95-1.41), the difference was not significant.
The researchers cited several possibilities for their findings, including changes in serum levels of circulation antiangiogenic factors among women with HDP, which may have an impact on ocular microvascular structure and ocular blood flow in their children. They also noted that HDP can cause excessive oxidative stress and inflammation throughout pregnancy, subsequently impacting various organ systems. Preeclamptic pregnancy also increases the risk of preterm birth, which carries a higher risk of RE due to placental dysfunction.
“In addition, risk of myopia was slightly greater among offspring aged 7 to 12 years, which may be due to the accompanying academic burden and worse eye habits,” wrote the researchers. “It is important to note that maternal HDP was associated with increased risk of all types of RE in offspring in our study, although the HRs were slightly different among different subtypes,” the study authors wrote. “This suggests that maternal HDP may be associated with short- and long-term abnormal refractive regulation through adverse intrauterine environment and with increased risk of high RE from birth to adolescence.”
The researchers also performed a sibling-matched analysis, which showed a significant increased risk of overall high RE in half siblings (HR, 1.21; 95% CI, 1.05-1.39) and an increased, but nonsignificant increase in full siblings (HR, 1.15; 95% CI, 0.99-1.34). Increased risk was seen among hypermetropia (HR, 1.41; 95% CI, 1.30-1.52), myopia (HR, 1.30; 95% CI, 1.10-1.53), and astigmatism (HR, 1.45; 95% CI, 1.22-1.71).
Reference
Li M, Huang C, Yang W, et al. Evaluation of hypertensive disorder of pregnancy and high refractive error in offspring during childhood and adolescence. JAMA Netw Open. 2023;6(4):e238694. doi:10.1001/jamanetworkopen.2023.8694
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
Building Trust, Breaking Barriers: Health Care Leaders Tackle Primary Care Challenges
August 8th 2024On this episode of Managed Care Cast, we're talking with the chief medical officers of CVS Health and Aetna, as well as CVS Health's chief health equity officer, about primary and preventive care engagement, the impact of telehealth, and the role of trust in patient-provider relationships.
Listen
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More